Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - October 1, 2017 Category: Hematology Authors: Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, Farhad Ravandi, Gautam Borthakur, Courtney DiNardo, Naval Daver, Tapan Kadia, Naveen Pemmaraju, Sherry Pierce, Guillermo Garcia ‐Manero, William Wierda, Srdan Verstovsek, Elias Jabbour, Jorge Cortes Tags: Research Article Source Type: research